---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-25-000052"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:44:08.820899+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare Q3 revenue up 6% to $5.1B; adjusted EPS down to $1.07 from $1.14; raises low end of FY guidance

## Summary
- Revenue $5.1B (+6% reported, +4% organic); organic orders +6% across all segments.
- Net income $446M ($0.98 diluted EPS) vs $470M ($1.02); adjusted EPS $1.07 vs $1.14.
- Segment EBIT margin declines: Imaging 10.2% (-260bps), Patient Care Solutions 3.7% (-680bps), Pharmaceutical Diagnostics 29.4% (-150bps).
- Full-year adjusted EPS guidance low end raised to $4.51-$4.63 (prev $4.43-$4.63); organic revenue ~3% growth reaffirmed.
- Management cites ~$265M tariff impact on adjusted EBIT and $0.45 on adjusted EPS; free cash flow $483M vs $651M prior year.

## SEC filing metadata
- accession: 0001932393-25-000052
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000052/0001932393-25-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000052/gehc-20251029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-25-000052
- JSON: https://secwatch.observer/filing/0001932393-25-000052.json
- Plain text: https://secwatch.observer/filing/0001932393-25-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.